What does Vericel Corp (VCEL) do?

Vericel Corp (VCEL) is a publicly traded company in the Healthcare sector.

What sector does VCEL operate in?

Vericel Corp operates in the Healthcare, specifically within the Biological Products, (No Diagnostic Substances) industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find VCEL earnings analysis?

AlphaOS publishes an earnings intelligence page for Vericel Corp (VCEL) covering results, guidance context, and AI-assisted analysis. See /stocks/VCEL/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

VCEL

Vericel Corp

Healthcare · Biological Products, (No Diagnostic Substances)

$40.61Sep 29, 2026

AI confidence 71% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

Vericel Corp shows stable business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue +22% YoY in Q2 FY2026.

TrajectoryStable

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue +22% YoY in Q2 FY2026

Pipeline evidence · 22d ago

VCEL's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on VCEL.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full VCEL earnings analysis

Reported figures for Vericel Corp — research only, not investment advice.

Revenue YoY: +22.5%

Latest Intelligence

Updated September 29, 2026

What happened recently for Vericel Corp (VCEL) — events, not interpretation.

Event: Reported Q2 2026 revenue +23% YoY.
Also: Last session September 29, 2026 at $40.61.
Source: Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

Vericel Corp (VCEL)

Healthcare · Biological Products, (No Diagnostic Substances)

Investment Snapshot above is the primary AlphaOS analysis for Vericel Corp — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Biological Products, (No Diagnostic Substances)
Market cap:: $2.08B
Revenue:: $77.46M

VCEL earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Vericel Corp through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.